We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
MacroGenics
MGNX
$257M
| $1.67M | ﹤0.01% |
189,400
+174,200
| +1,146% | +$1.92M |
|
827
Haverty Furniture Companies
HVT
$426M
| $1.67M | ﹤0.01% |
60,800
-2,100
| -3% | -$61K |
|
828
The RMR Group
RMR
$327M
| $1.66M | ﹤0.01% |
53,504
-1,500
| -3% | -$46.8K |
|
829
MasTec
MTZ
$17.9B
| $1.65M | ﹤0.01% |
19,000
-18,800
| -50% | -$1.64M |
|
830
ACI Worldwide
ACIW
$5.18B
| $1.65M | ﹤0.01% |
52,462
-16,848
| -24% | -$562K |
|
831
Restaurant Brands International
QSR
$26.3B
| $1.65M | ﹤0.01% |
28,241
+13,105
| +87% | +$745K |
|
832
Voya Financial
VOYA
$9.28B
| $1.64M | ﹤0.01% |
+24,700
| New | +$1.68M |
|
833
Pembina Pipeline
PBA
$27.5B
| $1.6M | ﹤0.01% |
42,671
-494
| -1% | -$16.7K |
|
|
ECOM
834
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $1.59M | ﹤0.01% |
95,700
-3,900
| -4% | -$74K |
|
|
EGRX
835
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.58M | ﹤0.01% |
+32,000
| New | +$1.54M |
|
|
TWTR
836
DELISTED
Twitter, Inc.
TWTR
| $1.58M | ﹤0.01% |
40,869
-1,597
| -4% | -$58.4K |
|
|
CSR
837
Centerspace
CSR
$972M
| $1.58M | ﹤0.01% |
+16,052
| New | +$1.56M |
|
838
RTX Corp
RTX
$263B
| $1.56M | ﹤0.01% |
15,760
-7,017
| -31% | -$665K |
|
839
OraSure Technologies
OSUR
$239M
| $1.56M | ﹤0.01% |
229,900
-7,800
| -3% | -$62.3K |
|
840
Columbia Financial
CLBK
$1.2B
| $1.56M | ﹤0.01% |
+159,289
| New | +$1.55M |
|
|
MPT
841
Medical Properties Trust
MPT
$2.11B
| $1.53M | ﹤0.01% |
72,521
-33,800
| -32% | -$728K |
|
842
MDU Resources
MDU
$3.91B
| $1.52M | ﹤0.01% |
150,429
| – | – |
|
843
G-III Apparel Group
GIII
$1.19B
| $1.51M | ﹤0.01% |
56,000
| – | – |
|
|
TUP
844
DELISTED
Tupperware Brands Corporation
TUP
| $1.51M | ﹤0.01% |
77,700
+2,700
| +4% | +$46K |
|
845
uniQure
QURE
$2.99B
| $1.51M | ﹤0.01% |
83,600
+73,400
| +720% | +$1.28M |
|
846
Opko Health
OPK
$1.17B
| $1.5M | ﹤0.01% |
436,100
+407,100
| +1,404% | +$1.44M |
|
|
AMK
847
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.47M | ﹤0.01% |
66,209
-49,691
| -43% | -$1.17M |
|
848
FirstService
FSV
$5.74B
| $1.47M | ﹤0.01% |
10,135
+1,524
| +18% | +$232K |
|
849
OneMain Financial
OMF
$7.08B
| $1.43M | ﹤0.01% |
30,200
| – | – |
|
|
CADE
850
DELISTED
Cadence Bank
CADE
| $1.42M | ﹤0.01% |
48,500
-100
| -0.2% | -$3.12K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.